|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
Pharmaceutical companies don’t want to be left behind and miss out on the opportunity to maximize their sales potential in this ballooning market. But doing business in Russia can be very risky.
Not only is Russia’s regulatory policy on drugs excessive, it’s also arbitrarily implemented with little regard to international regulations.
Imagine trying to keep up with:
Now you can get insider information on how to overcome these hurdles and get a handle on the regulatory environment in Russia. In this 90-minute Encore presentation experts Svetlana Rudevich and Julianna Tabastajewa share their real-world experiences so you can get your drugs through the Russian regulatory maze and onto the market.
Sign up your entire team to listen in and discover:
ou won’t want to miss out on this great opportunity to get your drugs into the hottest market in the world — register now! You’ll get a chance to ask your toughest questions during the Q&A session.
This presentation is a must for positions in drug and biotech companies, including:
Svetlana Rudevich of Hogan and Hartson, LLP, has extensive experience in various Russian corporate transactions, including cross-border mergers and acquisitions; setting up equity and debt financing; restructuring and liquidation of business operations; regulatory issues, including antitrust, currency control, customs, consumer protection and products compliance legislation; and a wide variety of labor law issues. Svetlana advises pharmaceutical companies on various legal and commercial issues related to the access of consumer goods and pharmaceuticals to the Russian market, including product compliance, certification and customs clearance.
Julianna Tabastajewa of Hogan and Hartson, LLP, focuses her practice on intellectual property protection and litigation, pharmaceutical law, competition law, media law and franchising. Julianna advises pharmaceutical and medical device companies on issues such as performing clinical trials and importing and distributing pharmaceutical products in Russia. She also has extensive experience in domestic litigations and arbitration in Russia. Julianna has contributed significantly to new domain regulations in the Russian Federation and has written extensively on the subject.
|Date:||July 28 – Aug. 15, 2008|
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing